Background Mesangial cell proliferation is a characteristic feature of IgA
nephropathy and many other forms of glomerulonephritis. Recent clinical stu
dies have shown that dietary fish oil supplementation retards renal disease
progression in patients with IgA nephropathy. The mechanism by which this
effect occurs is unknown.
Methods. The anti-Thy 1.1 (ATS) model of mesangial proliferative glomerulon
ephritis was employed to test the hypothesis that dietary fish oil suppleme
ntation reduces mesangial cell proliferation following acute injury. Subcul
tured rat mesangial cells were used to determine the in vitro effects of ei
cosapentaenoic acid (EPA) and docosahexaenoic acid (PHA), the primary compo
nents of fish oil, on proliferation.
Results. Following antithymocyte serum (ATS) administration, proteinuria wa
s significantly decreased in animals treated with fish oil compared with se
same oil-treated controls. In ATS rats given fish oil, there was Less mesan
gial cell and matrix expansion, mesangiolysis, or basement membrane disrupt
ion (Delta% = -40%). ATS rats receiving fish oil had less glomerular cell p
roliferation (PCNA-Delta% = -50%) and a reduction of cr-smooth muscle actin
expression (Delta% = -27%) by mesangial cells. Tn subcultured rat mesangia
l cells, DHA, but not EPA, significantly inhibited proliferation.
Conclusions. Fish oil inhibits mesangial cell activation and proliferation
in ATS glomerulonephritis, reduces proteinuria, and decreases histologic ev
idence of glomerular damage. In vitro, the antiproliferative effects of fis
h oil are more likely related to the action of DHA. We suggest that orally
administered fish oil, or purified DHA, may have a suppressive effect in ac
ute phases or relapses of glomerulopathies by inhibiting activation and pro
liferation of mesangial cells.